| [1] |
Poston CN, Krishnan SC, Bazemore-Walker CR.In-depth proteomic analysis of mammalian mitochondria-associated membranes(MAM)[J]． J Proteomics， 2013(79):219-230.DOI： 10.1016/j.jprot.2012.12.018.
|
| [2] |
Barazzuol L, Giamogante F, Calì T．Mitochondria associated membranes(MAMs)：architecture and physiopathological role[J]． Cell Calcium， 2021(94):102343.DOI： 10.1016/j.ceca.2020.102343.
|
| [3] |
Yang JY, Yang WY. Bit-by-bit autophagic removal of parkin-labelled mitochondria[J]． Nat Commun， 2013(4):2428.DOI： 10.1038/ncomms3428.
|
| [4] |
Kornmann B, Currie E, Collins SR, et al. An ER-mitochondria tethering complex revealed by a synthetic biology screen[J]． Science， 2009， 325(5939):477-481.DOI： 10.1126/science.1175088.
|
| [5] |
Gelmetti V, De Rosa P, Torosantucci L，et al.PINK1 and BECN1 relocalize at mitochondria-associated membranes during mitophagy and promote ER-mitochondria tethering and autophagosome formation[J]． Autophagy， 2017， 13(4):654-669.DOI： 10.1080/15548627.2016.1277309.
|
| [6] |
Pickrell AM, Youle RJ.The roles of PINK1，parkin，and mitochondrial fidelity in Parkinson's disease[J]． Neuron， 2015， 85(2):257-273.DOI： 10.1016/j.neuron.2014.12.007.
|
| [7] |
Birgisdottir ÅB, Lamark T, Johansen T．The LIR motif-crucial for selective autophagy[J]． J Cell Sci， 2013， 126(Pt 15):3237-3247.DOI： 10.1242/jcs.126128.
|
| [8] |
Wu W, Lin C, Wu K, et al. FUNDC1 regulates mitochondrial dynamics at the ER-mitochondrial contact site under hypoxic conditions[J]． EMBO J， 2016， 35(13):1368-1384.DOI： 10.15252/embj.201593102.
|
| [9] |
Li W, Zhang X, Zhuang H，et al.MicroRNA-137 is a novel hypoxia-responsive microRNA that inhibits mitophagy via regulation of two mitophagy receptors FUNDC1 and NIX[J]． J Biol Chem， 2014， 289(15):10691-10701.DOI： 10.1074/jbc.M113.537050.
|
| [10] |
Mercer TJ, Gubas A, Tooze SA.A molecular perspective of mammalian autophagosome biogenesis[J]． J Biol Chem， 2018， 293(15):5386-5395.DOI： 10.1074/jbc.R117.810366.
|
| [11] |
de Brito OM, Scorrano L．Mitofusin 2 tethers endoplasmic reticulum to mitochondria[J]． Nature， 2008， 456(7222):605-610.DOI： 10.1038/nature07534.
|
| [12] |
Missiroli S, Patergnani S, Caroccia N，et al.Mitochondria-associated membranes (MAMs) and inflammation[J]． Cell Death Dis， 2018， 9(3):329.DOI： 10.1038/s41419-017-0027-2.
|
| [13] |
Zhou R, Yazdi AS, Menu P，et al.A role for mitochondria in NLRP3 inflammasome activation[J]． Nature， 2011， 469(7329):221-225.DOI： 10.1038/nature09663.
|
| [14] |
Qu C, Li Y, Li Y，et al.Full-length MAVS，a mitochondrial antiviral-signaling protein，inhibits hepatitis E virus replication，requiring JAK-STAT signaling[J]． Arch Virol， 2022， 167(5):1293-1300.DOI： 10.1007/s00705-022-05415-9.
|
| [15] |
Bender S, Reuter A, Eberle F，et al.Activation of type Ⅰ and Ⅲ interferon response by mitochondrial and peroxisomal MAVS and inhibition by hepatitis C virus[J]． PLoS Pathog， 2015， 11(11):e1005264.DOI： 10.1371/journal.ppat.1005264.
|
| [16] |
Marquette A, Leborgne C, Schartner V，et al.Peptides derived from the C-terminal domain of HIV-1 viral protein R in lipid bilayers：structure，membrane positioning and gene delivery[J]． Biochim Biophys Acta Biomembr， 2020， 1862(2):183149.DOI： 10.1016/j.bbamem.2019.183149.
|
| [17] |
Petrungaro C, Kornmann B．Lipid exchange at ER-mitochondria contact sites：a puzzle falling into place with quite a few pieces missing[J]． Curr Opin Cell Biol， 2019(57):71-76.DOI： 10.1016/j.ceb.2018.11.005.
|
| [18] |
Sohn M, Korzeniowski M, Zewe JP，et al.PI(4，5)P2 controls plasma membrane PI4P and PS levels via ORP5/8 recruitment to ER-PM contact sites[J]． J Cell Biol， 2018， 217(5):1797-1813.DOI： 10.1083/jcb.201710095.
|
| [19] |
Wang C, Dai X, Wu S，et al.FUNDC1-dependent mitochondria-associated endoplasmic reticulum membranes are involved in angiogenesis and neoangiogenesis[J]． Nat Commun， 2021， 12(1):2616.DOI： 10.1038/s41467-021-22771-3.
|
| [20] |
Silva-Palacios A, Zazueta C, Pedraza-Chaverri J．ER membranes associated with mitochondria：possible therapeutic targets in heart-associated diseases[J]． Pharmacol Res， 2020(156):104758.DOI： 10.1016/j.phrs.2020.104758.
|
| [21] |
Tan Y, Zhang Z, Zheng C，et al.Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies：preclinical and clinical evidence[J]． Nat Rev Cardiol， 2020， 17(9):585-607.DOI： 10.1038/s41569-020-0339-2.
|
| [22] |
Wu S, Lu Q, Ding Y，et al.Hyperglycemia-driven inhibition of AMP-activated protein kinase α2 induces diabetic cardiomyopathy by promoting mitochondria-associated endoplasmic reticulum membranes in vivo[J]． Circulation， 2019， 139(16):1913-1936.DOI： 10.1161/CIRCULATIONAHA.118.033552.
|
| [23] |
Wu S, Lu Q, Wang Q，et al.Binding of FUN14 domain containing 1 with inositol 1，4，5-trisphosphate receptor in mitochondria-associated endoplasmic reticulum membranes maintains mitochondrial dynamics and function in hearts in vivo[J]． Circulation， 2017， 136(23):2248-2266.DOI： 10.1161/CIRCULATIONAHA.117.030235.
|
| [24] |
Eizirik DL, Pasquali L, Cnop M．Pancreatic β-cells in type 1 and type 2 diabetes mellitus：different pathways to failure[J]． Nat Rev Endocrinol， 2020， 16(7):349-362.DOI： 10.1038/s41574-020-0355-7.
|
| [25] |
Rieusset J．Contribution of mitochondria and endoplasmic reticulum dysfunction in insulin resistance：distinct or interrelated roles？[J]． Diabetes Metab， 2015， 41(5):358-368.DOI： 10.1016/j.diabet.2015.02.006.
|
| [26] |
Chen Y, Chen J, Zhang C，et al.Deficiency in the short-chain acyl-CoA dehydrogenase protects mice against diet-induced obesity and insulin resistance[J]． FASEB J， 2019， 33(12):13722-13733.DOI： 10.1096/fj.201901474RR.
|
| [27] |
Siasos G, Paschou SA, Tousoulis D．Mitochondria and diabetes[J]． Ann Transl Med， 2020， 8(6):262.DOI： 10.21037/atm.2020.03.15.
|
| [28] |
Tubbs E, Chanon S, Robert M，et al.Disruption of mitochondria-associated endoplasmic reticulum membrane (MAM) integrity contributes to muscle insulin resistance in mice and humans[J]． Diabetes， 2018， 67(4):636-650.DOI： 10.2337/db17-0316.
|
| [29] |
Rieusset J．Role of endoplasmic reticulum-mitochondria communication in type 2 diabetes[J]． Adv Exp Med Biol， 2017(997):171-186.DOI： 10.1007/978-981-10-4567-7_13.
|
| [30] |
Wu H, Wang Y, Li W，et al.Deficiency of mitophagy receptor FUNDC1 impairs mitochondrial quality and aggravates dietary-induced obesity and metabolic syndrome[J]． Autophagy， 2019， 15(11):1882-1898.DOI： 10.1080/15548627.2019.1596482.
|
| [31] |
Kharitonenkov A, DiMarchi R．Fibroblast growth factor 21 night watch：advances and uncertainties in the field[J]． J Intern Med， 2017， 281(3):233-246.DOI： 10.1111/joim.12580.
|
| [32] |
Jimenez V, Jambrina C, Casana E，et al.FGF21 gene therapy as treatment for obesity and insulin resistance[J]． EMBO Mol Med， 2018， 10(8):e8791.DOI： 10.15252/emmm.201708791.
|
| [33] |
Parys JB, Bultynck G, Vervliet T．IP(3) receptor biology and endoplasmic reticulum calcium dynamics in cancer[J]． Prog Mol Subcell Biol， 2021(59):215-237.DOI： 10.1007/978-3-030-67696-4_11.
|
| [34] |
Xu K, Chen G, Li X，et al.MFN2 suppresses cancer progression through inhibition of mTORC2/Akt signaling[J]． Sci Rep， 2017(7):41718.DOI： 10.1038/srep41718.
|
| [35] |
Rimessi A, Pedriali G, Vezzani B，et al.Interorganellar calcium signaling in the regulation of cell metabolism：a cancer perspective[J]． Semin Cell Dev Biol， 2020(98):167-180.DOI： 10.1016/j.semcdb.2019.05.015.
|
| [36] |
Rong YP, Bultynck G, Aromolaran AS，et al.The BH4 domain of Bcl-2 inhibits ER calcium release and apoptosis by binding the regulatory and coupling domain of the IP3 receptor[J]． Proc Natl Acad Sci U S A， 2009， 106(34):14397-14402.DOI： 10.1073/pnas.0907555106.
|
| [37] |
Wu L, Zhang D, Zhou L, et al. FUN14 domain-containing 1 promotes breast cancer proliferation and migration by activating calcium-NFATC1-BMI1 axis[J]． EBioMedicine， 2019(41):384-394.DOI： 10.1016/j.ebiom.2019.02.032.
|